GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
2

20/20 Biolabs, Inc. Common Stock AIDX · USD

US listing · 🇺🇸 United States

Compare

0.20

+1.88%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

20/20 Biolabs, Inc. Common Stock — daily AIDX Delayed
Market value
$2.1m
Last close × shares
Volume
140k
Shares, 9 Nov 2026

About 20/20 Biolabs, Inc. Common Stock

From its filings with the US Securities and Exchange Commission

SEC filings

20/20 Biolabs, Inc. Common Stock is based in Rockville, Maryland and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker AIDX. The SEC classifies its business as testing laboratories. In the fiscal year to 31 December 2025, it reported revenue of $2.0m and a net loss of $3.7m. At that date it held total assets of $4.1m and shareholders' equity of −$19,225.

Read the filing on SEC.gov ↗

More about 20/20 Biolabs, Inc. Common Stock →

Latest on 20/20 Biolabs, Inc. Common Stock

Our reporting

We have not reported on 20/20 Biolabs, Inc. Common Stock yet.

Next results

13 Nov 2026

Due on 13 Nov 2026.

Other United States listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is 20/20 Biolabs, Inc. Common Stock's ticker?

20/20 Biolabs, Inc. Common Stock trades as AIDX on its US listing, under ISIN US90138K1016.

What was 20/20 Biolabs, Inc. Common Stock's last closing price?

0.20 on 9 Nov 2026. The figure is in USD and is never converted.

When does 20/20 Biolabs, Inc. Common Stock next report results?

Results are expected on 13 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
SEC filings and our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.